The pre-clinical methylazoxymethanol acetate (MAM) rodent model of psychosis shows reduced parvalbumin expression in MAM-treated rats that may be linked to schizophrenia-like pathology (Gastambide et al. 2012). This evidence concerns the gene PVALB and schizophrenia.